ELV Trading Analysis - 11/19/2026 01:35 PM โ€” TRU-SENTIMENT

ELV (Elevance Health Inc.) at $390.98. True Sentiment Bearish, delta 40-60 call 39% / put 61%, call $77,030 vs put $121,140. RSI 42.8.

TRU-SENTIMENT ยท DeltaNeutral

ELV Trading Analysis - 11/19/2026 01:35 PM โ€” TRU-SENTIMENT

Options chain ยท Stock chart ยท Baseline chart

ELV (Elevance Health Inc.) at $390.98. True Sentiment Bearish, delta 40-60 call 39% / put 61%, call $77,030 vs put $121,140. RSI 42.8.

Symbol
ELV
Price
$390.98
Article bias (separate from True Sentiment)
bearish
Conviction
low
Published
2026-11-19 13:35:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

From the True Sentiment file (Delta 40-60 only): Sentiment is Bearish. Call dollar volume $77,030 (38.9%) vs put dollar volume $121,140 (61.1%) of $198,170 total. Only 18 of 950 options analyzed met filter (1.9%).

Call contracts 36 / put contracts 69 with equal 9 trades each side shows put-side dollar conviction dominates. Near-term directional positioning skews protective/bearish. Divergence: MACD mildly bullish but options flow bearish; spread engine flagged "Divergence detected between technical indicators and options sentiment."

Note: Options flow shows bearish conviction via 61.1% put dollar volume in Delta 40-60 band.

Key Statistics: ELV

$391.25 -2.52%
52-Week Range
$274.84 - $450.69
Market Cap
$84.53B
P/E (TTM)
18.20
PEG Ratio
N/A
Beta
0.77
Next Earnings
N/A
Avg Volume
$782,801
Dividend Yield
0.02%

Fundamental Snapshot

Valuation

P/E (trailing)18.20
EPS (trailing 12 mo)$23.78
Market cap$84.53B
Shares outstanding216.1M

Dividend

Dividend yield1.59%
Annual dividend$6.88
Ex-dividend date2026-12-04

Risk & range

Beta0.77
52-week low$274.84
52-week high$450.69
Historical volatility38.4%

Ownership & trading

Institutional ownership63.9%
Average daily volume1.4M sh

Reported figures; no analyst estimates.


๐Ÿ“ˆ Analysis

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below. They are provided for contextual background only.

  • ELV (Elevance Health) faced ongoing Medicaid reimbursement pressure in several states, weighing on managed-care sector sentiment through late 2026.
  • Recent sector headlines highlighted rising medical cost trends, prompting cautious commentary from analysts on insurer margin outlooks.
  • ELV's ex-dividend date is scheduled for 2026-12-04 with a dividend rate of $6.88, a near-term shareholder event.
  • No major earnings catalyst was widely flagged before the next monthly options expiration (2026-12-18), though regulatory scrutiny remained a backdrop.
  • Context: Headlines around cost pressure align with the bearish options sentiment and a sharp down-day in the embedded price data, but technicals show no clear directional trend.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for ELV:

  • Trailing P/E is 18.20 and trailing EPS is $23.78; forward P/E, PEG ratio, and price-to-book are null (not available).
  • Market cap is $84.53B with 216.06M shares outstanding and institutional ownership at 63.91%.
  • Dividend yield is 1.59% with a rate of $6.88 and ex-dividend date 2026-12-04.
  • Beta is 0.77 (below 1.0, lower relative volatility); 52-week range is $274.84 to $450.69.
  • Revenue growth, gross/operating/net margins, ROE, debt-to-equity, and free cash flow are null in the data โ€” not available for trend review.
  • Analyst consensus, target mean price, and number of opinions are null; no street target context provided.
  • Fundamentals show stable valuation (P/E 18.20) and defensive beta, but absent margin/data limits alignment check vs the weak technical and bearish sentiment picture.

Current Market Position

From the embedded daily and minute data: The daily close on 2026-11-18 was $401.35 after opening at $431.87 and trading as low as $400.66 on volume of 1,435,168 (above the 20-day avg of 822,277). The last minute bars on 2026-11-19 show price near $390.98 (13:05 bar) after dipping from $431.87 area two sessions prior.

Intraday momentum on 2026-11-19 was soft early then stabilized: 12:45โ€“13:05 bars ranged $389.36โ€“$391.42 with closing ticks $389.80 โ†’ $389.36 โ†’ $389.66 โ†’ $391.42 โ†’ $390.98. Volume peaked at 39,053 in the 13:00 bar, suggesting late-morning buying attempt that faded.

Support
$400.66
Resistance
$431.87
30d Low
$397.12
30d High
$450.69

Technical Analysis

Technical Indicators

Current Price
$401.35
SMA 5
$427.89
SMA 20
$426.38
SMA 50
$416.92
RSI 14
42.80
MACD
2.02
Signal
1.61
Hist
0.40
BB Mid
$426.38
BB Up
$449.40
BB Low
$403.37
ATR 14
$15.62

Price ($401.35) is below SMA 5 ($427.89), SMA 20 ($426.38), and SMA 50 ($416.92) โ€” bearish alignment with no golden cross. RSI at 42.80 shows weak/mid momentum, not oversold. MACD (2.02) above signal (1.61) with positive histogram (0.40) is mildly bullish, conflicting with price below MAs. Bollinger lower band is $403.37; price is just under it, near lower-band expansion. 30-day range $397.12โ€“$450.69: price sits in the lower 10% of the range.

True Sentiment Analysis (Delta 40-60 Options)

From the True Sentiment file (Delta 40-60 only): Sentiment is Bearish. Call dollar volume $77,030 (38.9%) vs put dollar volume $121,140 (61.1%) of $198,170 total. Only 18 of 950 options analyzed met filter (1.9%).

Call contracts 36 / put contracts 69 with equal 9 trades each side shows put-side dollar conviction dominates. Near-term directional positioning skews protective/bearish. Divergence: MACD mildly bullish but options flow bearish; spread engine flagged "Divergence detected between technical indicators and options sentiment."

Note: Options flow shows bearish conviction via 61.1% put dollar volume in Delta 40-60 band.

Key Price Levels (Observational Only)

Daily Low 11-18
$400.66
BB Lower
$403.37
30d Low
$397.12
SMA 50
$416.92
SMA 20
$426.38
SMA 5
$427.89

Interactive charts load with JavaScript. This text is the crawlable summary.